Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma
Conclusions: These findings suggest that MSI-1 overexpression is associated with the prognosis of OC patients, and knockdown of MSI-1 can suppress malignant properties and reverse paclitaxel-resistance in OC cells. MSI-1 maybe act as a potential prognostic indicator and a therapeutic target in OC.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Huaizeng Chen, Jia Liu, Hanzhi Wang, Qi Cheng, Caiyun Zhou, Xiaojing Chen, Feng Ye Tags: Research Paper Source Type: research
More News: Borderline Serous Tumor | Borderline Tumor | Cancer | Cancer & Oncology | Carcinoma | Cystadenoma | Ovarian Cancer | Ovaries | Serous Carcinoma | Stem Cell Therapy | Stem Cells | Study